- Previous Close
0.00 - Open
39.00 - Bid 32.43 x 29200
- Ask 33.08 x 45900
- Day's Range
39.00 - 39.00 - 52 Week Range
32.58 - 50.49 - Volume
375 - Avg. Volume
62 - Market Cap (intraday)
6.94B - Beta (5Y Monthly) 0.92
- PE Ratio (TTM)
16.88 - EPS (TTM)
1.93 - Earnings Date May 5, 2025 - May 9, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Demant A/S operates as a hearing healthcare company in Europe, North America, Asia, Pacific region, and internationally. It engages in the development, manufacture, and wholesale of hearing aids and personalized hearing care products, as well as offers hearing and balance assessment solutions used by audiologists, ENT doctors, and balance clinics. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019. Demant A/S was founded in 1904 and is headquartered in Smørum, Denmark.
www.demant.comRecent News: WILLF
View MorePerformance Overview: WILLF
Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is OMX Copenhagen 25 Index (^OMXC25) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: WILLF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: WILLF
View MoreValuation Measures
Market Cap
6.98B
Enterprise Value
9.09B
Trailing P/E
16.92
Forward P/E
16.21
PEG Ratio (5yr expected)
0.77
Price/Sales (ttm)
2.18
Price/Book (mrq)
5.02
Enterprise Value/Revenue
2.80
Enterprise Value/EBITDA
10.83
Financial Highlights
Profitability and Income Statement
Profit Margin
10.65%
Return on Assets (ttm)
8.66%
Return on Equity (ttm)
30.47%
Revenue (ttm)
22.42B
Net Income Avi to Common (ttm)
2.89B
Diluted EPS (ttm)
1.93
Balance Sheet and Cash Flow
Total Cash (mrq)
1.11B
Total Debt/Equity (mrq)
162.60%
Levered Free Cash Flow (ttm)
2.81B